Financials
- Market Capitalization 33.01 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
2.8
売上高対価格比率
0.88
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4396 | KYNB Kyntra Bio, Inc. - Common Stock | 8.33 USD | -1.88% | +5.18% | +17.99% | -12.41% | 33.73 M USD | ||
| 4401 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.39 USD | +1.46% | -17.26% | +24.11% | -65.93% | 33.38 M USD | ||
| 4420 | CNTX Context Therapeutics Inc. - Common Stock | 0.35 USD | -2.78% | -10.26% | -44.44% | -57.32% | 32.16 M USD | ||
| 4429 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.76 USD | +5.56% | +8.57% | +33.33% | -39.68% | 31.05 M USD |